nach oben

Cognitive Therapy and Research

Erschienen in:

10.01.2018 | Original Article

Implicit Identification with Illness in Patients with Irritable Bowel Syndrome (IBS)

verfasst von: Julia F. Henrich, Bergljot Gjelsvik, Maryanne Martin

Erschienen in: Cognitive Therapy and Research | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Identification with pain has been linked to symptom severity in chronic pain conditions. However, the role of identification with illness in patients with Irritable Bowel Syndrome (IBS) is unknown. We investigated whether participants with IBS show identification with illness and if the degree of illness identification is related to IBS symptom severity and additional physical and psychological variables. In this cross-sectional study, 42 participants with IBS and 41 healthy participants completed an Implicit Association Test (IAT) to measure their level of identification with illness and health. Data on illness duration, explicit illness associations, IBS severity, depression, anxiety, stress and additional symptoms were obtained. IBS participants scored significantly lower on identification with health than healthy participants. The level of health identification was negatively correlated with ‘Nonspecific Somatic Symptoms’. Reduced health identification may be a maintaining factor of IBS that could be targeted with psychological treatments to reduce symptoms. Further, it may be possible to use the IAT to monitor the course of recovery.

Abramowitz, J. S., Tolin, D. F., & Street, G. P. (2001). Paradoxical effects of thought suppression: A meta-analysis of controlled studies. Clinical Psychology Review 21(5), 683–703. https://doi.org/10.1016/S0272-7358(00)00057-X.CrossRefPubMed

Baer, R. A. (2003). Mindfulness training as a clinical intervention: A conceptual and empirical review. Clinical Psychology: Science and Practice, 10(2), 125–143. https://doi.org/10.1093/clipsy/bpg015.

Blanchard, E. B., Greene, B., Scharff, L., & Schwarz-McMorris, S. P. (1993). Relaxation training as a treatment for irritable bowel syndrome. Biofeedback and Self-Regulation, 18(3), 125–132. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8218507.

Blanchard, E. B., Lackner, J. M., Sanders, K. A., Krasner, S. S., Keefer, L., Payne, A., … Dulgar-Tulloch, L. (2007). A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome. Behaviour Research and Therapy, 45(4), 633–648. https://doi.org/10.1016/j.brat.2006.07.003.CrossRefPubMed

Brooks, C. M., Richards, J. M., Bailey, W. C., Martin, B., Windsor, R., & Soong, S. J. (1989). Subjective symptomatology of asthma in an outpatient population. Psychosomatic Medicine, 51(1), 102–108. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/2928458.

Buckley, M. M., O’Mahony, S. M., & O’Malley, D. (2014). Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World Journal of Gastroenterology: WJG, 20(27), 8846–8858. https://doi.org/10.3748/wjg.v20.i27.8846.PubMedPubMedCentral

Cash, B., Sullivan, S., & Barghout, V. (2005). Total costs of IBS: Employer and managed care perspective. The American Journal of Managed Care, 11(1 Suppl), S7–S16. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15926759.

Chang, L., Toner, B. B., Fukudo, S., Guthrie, E., Locke, G. R., Norton, N. J., & Sperber, A. D. (2006). Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology, 130(5), 1435–1446. https://doi.org/10.1053/j.gastro.2005.09.071.CrossRefPubMed

Chilcot, J., & Moss-Morris, R. (2013). Changes in illness-related cognitions rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioural therapy intervention. Behaviour Research and Therapy, 51(10), 690–695. https://doi.org/10.1016/j.brat.2013.07.007.CrossRefPubMed

Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hoboken: Taylor & Francis.

Crane, C., & Martin, M. (2002). Perceived vulnerability to illness in individuals with irritable bowel syndrome. Journal of Psychosomatic Research, 53(6), 1115–1122. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12479994.

Crane, C., & Martin, M. (2004). Risk perception in individuals with irritable bowel syndrome: Perceived susceptibility to health and non-health threats. Journal of Social and Clinical Psychology, 23(2), 216–239. https://doi.org/10.1521/jscp.23.2.216.31016.CrossRef

Drossman, D. A. (2006). The functional gastrointestinal disorders and the Rome III process. Gastroenterology, 130(5), 1377–1390. https://doi.org/10.1053/j.gastro.2006.03.008.CrossRefPubMed

Drossman, D. A., Toner, B. B., Whitehead, W. E., Diamant, N. E., Dalton, C. B., Duncan, S., … Bangdiwala, S. I. (2003). Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157). Gastroenterology, 125(1), 19–31. https://doi.org/10.1016/S0016-5085(03)00669-3.CrossRefPubMed

Elsenbruch, S. (2011). Abdominal pain in irritable bowel syndrome: A review of putative psychological, neural and neuro-immune mechanisms. Brain, Behavior, and Immunity, 25(3), 386–394. https://doi.org/10.1016/j.bbi.2010.11.010.CrossRefPubMed

Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., … Spiller, R. C. (2016). Irritable bowel syndrome. Nature Reviews Disease Primers, 2(March), 16014. https://doi.org/10.1038/nrdp.2016.14.PubMedPubMedCentral

Faul, F., Erdfelder, E., Lang, A-G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39(2), 175–191.CrossRefPubMed

Faul, F. (2014). G*Power. Kiel: Universität Kiel.

Ford, A. C. (2014). Central pain processing in irritable bowel syndrome is modulated by mood: A mechanism for the beneficial effects of antidepressants? Gastroenterology. https://doi.org/10.1053/j.gastro.2014.11.017.

Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009). Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: Systematic review and meta-analysis. Gut, 58(3), 367–378. https://doi.org/10.1136/gut.2008.163162.CrossRefPubMed

Foxx-Orenstein, A. E. (2016). New and emerging therapies for the treatment of irritable bowel syndrome: An update for gastroenterologists. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756283X16633050.PubMedPubMedCentral

Gaynes, B. N., & Drossman, D. A. (1999). The role of psychosocial factors in irritable bowel syndrome. Baillière’s Best Practice & Research Clinical Gastroenterology, 13(3), 437–452. https://doi.org/10.1053/bega.1999.0038.CrossRef

Greenwald, A. G., Mcghee, D. E., & Schwartz, J. L. K. (1998). Measuring individual differences in implicit cognition. Journal of Personality and Social Psychology, 74(6), 1464–1480.CrossRefPubMed

Greenwald, A. G., Nosek, B. A., & Banaji, M. R. (2003). Understanding and using the Implicit Association Test: I. An improved scoring algorithm. Journal of Personality and Social Psychology, 85(2), 197–216. https://doi.org/10.1037/0022-3514.85.2.197.CrossRefPubMed

Greenwald, A. G., Poehlman, T. A., Uhlmann, E. L., & Banaji, M. R. (2009). Understanding and using the Implicit Association Test: III. Meta-analysis of predictive validity. Journal of Personality and Social Psychology, 97(1), 17–41. https://doi.org/10.1037/a0015575.CrossRefPubMed

Grundmann, O., & Yoon, S. L. (2010). Irritable bowel syndrome: Epidemiology, diagnosis and treatment: an update for health-care practitioners. Journal of Gastroenterology and Hepatology, 25(4), 691–699. https://doi.org/10.1111/j.1440-1746.2009.06120.x.CrossRefPubMed

Hadash, Y., Plonsker, R., Vago, D. R., & Bernstein, A. (2016). Experiential self-referential and selfless processing in mindfulness and mental health: Conceptual model and implicit measurement methodology. Psychological Assessment, 28(7), 856–869. https://doi.org/10.1037/pas0000300.CrossRefPubMed

Halland, M., & Saito, Y. A. (2015). Irritable bowel syndrome: new and emerging treatments. bmj, 350, h1622. https://doi.org/10.1136/bmj.h1622.CrossRefPubMed

Hayes, A. F. (2013). Introduction to mediation, moderation, and conditional process analysis. New York: Guilford Press.

Hayes, S. C., Follette, V. M., & Linehan, M. (Eds.). (2004). Mindfulness and acceptance. Expanding the cognitive-behavioral tradition. New York: The Guilford Press.

Henrich, J. F., Knittle, K., de Gucht, V., Warren, S., Dombrowski, S. U., & Maes, S. (2015). Identifying effective techniques within psychological treatments for irritable bowel syndrome: A meta-analysis. Journal of Psychosomatic Research, 78, 205–222.CrossRefPubMed

Henry, J. D., & Crawford, J. R. (2005). The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample. The British Journal of Clinical Psychology/The British Psychological Society, 44(Pt 2), 227–239. https://doi.org/10.1348/014466505X29657.CrossRef

IBM Corp. (2013). IBM SPSS Statistics for Macintosh, Version 22.0. Armonk, NY: IBM Corp.

Kinsman, R. A., Luparello, T., O’Banion, K., & Spector, S. (1973). Multidimensional analysis of the subjective symptomatology of asthma. Psychosomatic Medicine, 35(3), 250–267. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/4710144.

Lackner, J. M., Keefer, L., Jaccard, J., Firth, R., Brenner, D., Bratten, J., … Byroads, M. (2012). The Irritable Bowel Syndrome Outcome Study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome. Contemporary Clinical Trials, 33(6), 1293–1310. https://doi.org/10.1016/j.cct.2012.07.013.CrossRefPubMedPubMedCentral

Lackner, J. M., Mesmer, C., Morley, S., Dowzer, C., & Hamilton, S. (2004). Psychological treatments for irritable bowel syndrome: A systematic review and meta-analysis. Journal of Consulting and Clinical Psychology, 72(6), 1100–1113. https://doi.org/10.1037/0022-006X.72.6.1100.CrossRefPubMed

Lau, M. A., Segal, Z. V., & Williams, J. M. G. (2004). Teasdale’s differential activation hypothesis: Implications for mechanisms of depressive relapse and suicidal behaviour. Behaviour Research and Therapy, 42(9), 1001–1017. https://doi.org/10.1016/j.brat.2004.03.003.CrossRefPubMed

LimeSurvey Project Team, & Schmitz, C. (2015). LimeSurvey: An open source survey tool. Hamburg: LimeSurvey Project. Retrieved from http://www.limesurvey.org.

Lovell, R. M., & Ford, A. C. (2012). Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 10(7), 712–721.e4. https://doi.org/10.1016/j.cgh.2012.02.029.CrossRef

Lovibond, S. H., & Lovibond, P. F. (1995). Manual for the depression anxiety stress scales. Sydney: Psychology Foundation of Australia.

Lydiard, R. B. (2001). Irritable bowel syndrome, anxiety, and depression: What are the links. Journal of Clinical Psychiatry, 62(Suppl 8), 38–45.

Magee, J. C., Harden, K. P., & Teachman, B. A. (2012). Psychopathology and thought suppression: A quantitative review. Clinical Psychology Review, 32(3), 189–201. https://doi.org/10.1016/j.cpr.2012.01.001.CrossRefPubMedPubMedCentral

Martin, M., & Crane, C. (2003). Cognition and the body: Somatic attributions in irritable bowel syndrome. Behavioural and Cognitive Psychotherapy, 31(1), 13–31. https://doi.org/10.1017/S1352465803001036.CrossRef

National Institute for Health and Care Excellence [NICE]. (2008). Irritable bowel syndrome in adults: Diagnosis and management. Retrieved from https://www.nice.org.uk/guidance/cg61.

Nosek, B., Greenwald, A. G., & Banaji, M. R. (2005). Understanding and using the Implicit Association Test: II. Method variables and construct validity. Personality & Social Psychology Bulletin, 31(2), 166–180. https://doi.org/10.1177/0146167204271418.CrossRef

Öhman, L., Törnblom, H., & Simrén, M. (2014). Crosstalk at the mucosal border: Importance of the gut microenvironment in IBS. Nature Reviews Gastroenterology & Hepatology, 12(1), 36–49. https://doi.org/10.1038/nrgastro.2014.200.CrossRef

Olejnik, S., & Algina, J. (2000). Measures of effect size for comparative studies: Applications, interpretations, and limitations. Contemporary Educational Psychology, 25, 241–286. https://doi.org/10.1006/ceps.2000.1040.CrossRefPubMed

Phillips, K., & Clauw, D. J. (2011). Central pain mechanisms in chronic pain states—maybe it is all in their head. Best Practice & Research. Clinical Rheumatology, 25(2), 141–154. https://doi.org/10.1016/j.berh.2011.02.005.CrossRef

Pincus, T., & Morley, S. (2001). Cognitive-processing bias in chronic pain: A review and integration. Psychological Bulletin, 127(5), 599–617. https://doi.org/10.1037//0033-2909.127.5.599.CrossRefPubMed

Psychology Software Tools, I. (2012). E-Prime 2.0. Retrieved from http://www.pstnet.com.

Rao, S. S. C., Yu, S., & Fedewa, A. (2015). Systematic review: Dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 41(12), 1256–1270. https://doi.org/10.1111/apt.13167.CrossRefPubMed

Riebel, K., Egloff, B., & Witthöft, M. (2013). The implicit health-related self-concept in somatoform disorders. Journal of Behavior Therapy and Experimental Psychiatry, 44(3), 335–342. https://doi.org/10.1016/j.jbtep.2013.02.001.CrossRefPubMed

Schnabel, K., Asendorpf, J. B., & Greenwald, A. G. (2008). Assessment of individual differences in implicit cognition. European Journal of Psychological Assessment, 24(4), 210–217. https://doi.org/10.1027/1015-5759.24.4.210.CrossRef

Schoepfer, A. M., Trummler, M., Seeholzer, P., Seibold-Schmid, B., & Seibold, F. (2008). Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflammatory Bowel Diseases, 14(1), 32–39. https://doi.org/10.1002/ibd.20275.CrossRefPubMed

Segal, Z. V., Williams, J. M. G., & Teasdale, J. D. (2013). Mindfulness-based cognitive therapy for depression (2nd ed.). New York: The Guilford Press.

Sibelli, A., Chalder, T., Everitt, H., Workman, P., Windgassen, S., & Moss-Morris, R. (2016). A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset. Psychological Medicine. https://doi.org/10.1017/S0033291716001987.PubMed

Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., … Whorwell, P. (2007). Guidelines on the irritable bowel syndrome: Mechanisms and practical management. Gut, 56(12), 1770–1798. https://doi.org/10.1136/gut.2007.119446.CrossRefPubMedPubMedCentral

Teachman, B. A., Marker, C. D., & Smith-Janik, S. B. (2008). Automatic associations and panic disorder: Trajectories of change over the course of treatment. Journal of Consulting and Clinical Psychology, 76(6), 988–1002. https://doi.org/10.1037/a0013113.CrossRefPubMedPubMedCentral

Teasdale, J. D. (1988). Cognitive vulnerability to persistent depression. Cognition & Emotion, 2(3), 247–274. https://doi.org/10.1080/02699938808410927.CrossRef

Thakur, E. R., Quigley, B. M., El-Serag, H. B., Gudleski, G. D., & Lackner, J. M. (2016). Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age. Journal of Psychosomatic Research, 88, 48–53. https://doi.org/10.1016/j.jpsychores.2016.07.006.CrossRefPubMedPubMedCentral

Van Ryckeghem, D. M. L., De Houwer, J., Van Bockstaele, B., Van Damme, S., De Schryver, M., & Crombez, G. (2013). Implicit associations between pain and self-schema in patients with chronic pain. Pain, 154(12), 2700–2706. https://doi.org/10.1016/j.pain.2013.07.055.CrossRefPubMed

Vasan, R. S. (2006). Biomarkers of cardiovascular disease: Molecular basis and practical considerations. Circulation, 113(19), 2335–2362. https://doi.org/10.1161/CIRCULATIONAHA.104.482570.CrossRefPubMed

Watkins, E., & Moulds, M. (2005). Distinct modes of ruminative self-focus: Impact of abstract versus concrete rumination on problem solving in depression. Emotion (Washington, DC), 5(3), 319–328. https://doi.org/10.1037/1528-3542.5.3.319.CrossRef

Wenzlaff, R. M., & Wegner, D. M. (2000). Thought suppression. Depression, 51, 59–91.

WGO Advisory Board. (2007). Systematic review on the management of irritable bowel syndrome in the European Union. European Journal of Gastroenterology & Hepatology, 19(Suppl 1), 11–37. https://doi.org/10.1097/01.meg.0000252641.64656.41.

Whitehead, W. E., Palsson, O., & Jones, K. R. (2002). Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology, 122(4), 1140–1156. https://doi.org/10.1053/gast.2002.32392.CrossRefPubMed

Wiklund, I. K., Fullerton, S., Hawkey, C. J., Jones, R. H., Longstreth, G. F., Mayer, E. A., … Naesdal, J. (2003). An irritable bowel syndrome-specific symptom questionnaire: Development and validation. Scandinavian Journal of Gastroenterology, 38(9), 947–954. https://doi.org/10.1080/00365520310004209.CrossRefPubMed

Williams, J. M. G. (2008). Mindfulness, depression and modes of mind. Cognitive Therapy and Research, 32(6), 721–733. https://doi.org/10.1007/s10608-008-9204-z.CrossRef

Wilson, S., Roberts, L., Roalfe, A., Bridge, P., & Singh, S. (2004). Prevalence of irritable bowel syndrome: a community survey. The British Journal of General Practice: The Journal of the Royal College of General Practitioners, 54(504), 495–502. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1324800&tool=pmcentrez&rendertype=abstract.

Windgassen, S., Moss-Morris, R., Chilcot, J., Sibelli, A., Goldsmith, K., & Chalder, T. (2017). The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome. British Journal of Health Psychology. https://doi.org/10.1111/bjhp.12250.PubMed

Titel: Implicit Identification with Illness in Patients with Irritable Bowel Syndrome (IBS)
verfasst von: Julia F. Henrich
Bergljot Gjelsvik
Maryanne Martin
Publikationsdatum: 10.01.2018
Verlag: Springer US
Erschienen in: Cognitive Therapy and Research / Ausgabe 3/2018
Print ISSN: 0147-5916
Elektronische ISSN: 1573-2819
DOI: https://doi.org/10.1007/s10608-017-9888-z

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Unwanted Events and Side Effects in Cognitive Behavior Therapy

Modelling the Relationship Between Changes in Social Anxiety and Rumination Before and After Treatment

Homework Completion via Telephone and In-Person Cognitive Behavioral Therapy Among Latinos

Group Cognitive Rehabilitation and Exposure/Sorting Therapy: A Pilot Program